EPA vs DHA: What's the Difference and Which Do You Actually Need?

EPA vs DHA: What's the Difference and Which Do You Actually Need?

โš ๏ธ Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any health decisions.

Walk into any supplement store and you will find dozens of fish oil products. Some boast high DHA. Others lead with EPA. Many list a combined EPA+DHA figure and leave you to guess the rest. Most people buying fish oil have no idea that these two omega-3 fatty acids do substantially different things in the body โ€” and that taking the wrong ratio for your specific goals may mean you are not getting the benefit you are paying for.

This article explains exactly what EPA and DHA are, what each one does, and how to choose the right fish oil for your situation based on the current evidence.

The Basics: What Are EPA and DHA?

Both EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long-chain polyunsaturated omega-3 fatty acids found primarily in the fatty tissues of cold-water marine fish. They are called "essential" fatty acids not because your body cannot make them at all, but because the human body converts only about 1โ€“10% of the plant-based omega-3 ALA (from flaxseed, chia, walnuts) into EPA, and less than 1% into DHA. For practical purposes, you need to obtain EPA and DHA directly from oily fish or fish oil supplements.

Despite being closely related chemically โ€” DHA has 22 carbon atoms, EPA has 20 โ€” they behave quite differently once inside your body.

What EPA Does

EPA's primary role in the body is anti-inflammatory signalling. It competes directly with arachidonic acid (an omega-6 fatty acid) for the same enzymes โ€” COX and LOX โ€” that produce pro-inflammatory prostaglandins and leukotrienes. When EPA wins that competition, the result is the production of resolvins and protectins โ€” specialised molecules that actively resolve inflammation rather than simply suppressing it.

This makes EPA the dominant omega-3 for conditions driven by chronic inflammation:

  • Cardiovascular disease: High-dose EPA (as in the prescription drug Vascepa/icosapentaenoic acid ethyl ester used in the REDUCE-IT trial) significantly reduces triglycerides and cardiovascular events. The American Heart Association specifically endorses EPA for triglyceride management.
  • Depression and mood: A 2019 meta-analysis in Translational Psychiatry found that EPA-dominant formulations (EPAโ‰ฅ60% of total omega-3) were significantly more effective for depression than DHA-dominant ones. EPA's anti-inflammatory effect on neuroinflammation โ€” increasingly recognised as a driver of depression โ€” appears to be the key mechanism.
  • Joint pain and arthritis: Multiple RCTs show EPA-rich fish oil reduces joint tenderness, morning stiffness, and NSAID requirements in rheumatoid arthritis patients.
  • Skin health: EPA reduces the inflammatory response that drives acne, eczema, and psoriasis, and protects against UV-induced skin damage.

What DHA Does

DHA is a structural fatty acid. Rather than acting primarily as a signalling molecule like EPA, DHA is a physical component of cell membranes โ€” particularly in the brain and eyes, where it is present in extraordinary concentrations. Approximately 97% of the omega-3 fatty acids in the brain are DHA. It makes up 93% of the omega-3 content of the retina.

DHA's structural presence in neural tissue is not passive โ€” it directly influences how flexible and fluid cell membranes are, which in turn affects how efficiently neurons transmit signals, how quickly neurotransmitter receptors respond, and how effectively synaptic connections form and maintain.

DHA is therefore the dominant omega-3 for:

  • Brain development: DHA is critical during pregnancy and early childhood for brain and nervous system formation. Low maternal DHA is associated with preterm birth, lower birth weight, and impaired infant cognitive development. Most prenatal omega-3 supplements are DHA-dominant for this reason.
  • Cognitive function and dementia prevention: DHA deficiency is consistently associated with cognitive decline and increased Alzheimer risk. Population studies show that adults with higher DHA blood levels have significantly larger brain volumes and better memory performance in later life.
  • Eye health: DHA is essential for retinal function. Deficiency impairs visual acuity and increases risk of age-related macular degeneration (AMD).
  • ADHD in children: Research suggests DHA supplementation improves attention and behaviour in children with ADHD, likely through supporting prefrontal cortex development.

Where They Overlap

Both EPA and DHA contribute to cardiovascular health โ€” they both reduce triglycerides and have anti-platelet effects that reduce clotting risk. Both support general anti-inflammatory activity, though through different mechanisms. For general health maintenance without a specific condition in mind, a balanced EPA+DHA supplement makes sense.

The Ratio Question: What Does the Research Say?

Most standard fish oil supplements provide EPA and DHA in a roughly 3:2 ratio (e.g., 180mg EPA / 120mg DHA per 1,000mg capsule). This mirrors the natural ratio found in many cold-water fish and is a reasonable general-purpose formulation.

However, for specific goals, the ratio matters considerably:

  • For depression/mood: Look for EPAโ‰ฅ60% of combined EPA+DHA. Products labelled "EPA-dominant" or with โ‰ฅ1,000mg EPA per serving are most relevant to the clinical evidence.
  • For pregnancy/infant development: Prioritise DHA โ€” at least 200mg DHA daily during pregnancy is the standard recommendation.
  • For cardiovascular/triglyceride reduction: High-dose EPA (2โ€“4g daily) has the most robust evidence. The REDUCE-IT trial used 4g of pure EPA ethyl ester daily.
  • For cognitive ageing/dementia prevention: DHA-rich formulations (DHAโ‰ฅ500mg) are most relevant.
  • For general anti-ageing: A balanced high-dose formulation providing at least 500mg EPA + 500mg DHA daily is appropriate.

The Form Question: rTG vs Ethyl Ester

Beyond the EPA/DHA ratio, the molecular form of omega-3 in your supplement significantly affects how well your body absorbs it. The key distinction:

  • Re-esterified triglycerides (rTG): The closest form to natural fish oil. Bioavailability is approximately 70% higher than ethyl esters. Premium fish oil supplements use this form.
  • Ethyl esters (EE): The most common and cheapest form. Produced by replacing the glycerol backbone with ethanol during concentration. Lower bioavailability, especially if taken without a fat-containing meal.
  • Natural triglycerides (NTG): Found in whole fish and some minimally processed oils. Good bioavailability, but lower EPA+DHA concentration per capsule.
  • Phospholipids: The form found in krill oil. Some studies suggest slightly higher bioavailability than fish oil TG form, though the evidence is mixed.

The practical implication: if you are taking a standard ethyl ester fish oil, always take it with your highest-fat meal of the day. This alone can increase EPA and DHA absorption by 50% or more.

How to Choose the Right Fish Oil

Based on the evidence, here is a practical decision framework:

  • General health / anti-ageing: Balanced EPA+DHA, minimum 1,000mg combined daily, rTG form preferred
  • Depression or mood support: EPA-dominant (โ‰ฅ60% EPA), 1,000โ€“2,000mg EPA daily
  • Brain health / cognitive protection: DHA-rich, minimum 500mg DHA daily
  • High triglycerides / heart disease risk: High-dose EPA, 2โ€“4g daily โ€” discuss prescription options (Vascepa, Lovaza) with your doctor
  • Pregnancy: At least 200mg DHA daily, ideally 400โ€“600mg
  • Joint pain / inflammation: High EPA, 2โ€“3g combined daily

Whatever formulation you choose, look for third-party purity certification (IFOS, NSF, or USP) to verify the product is free from heavy metals, PCBs, and oxidised oil โ€” quality issues that affect a surprising proportion of commercial fish oil products.

References

  1. Sublette ME, et al. (2011). Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Journal of Clinical Psychiatry, 72(12), 1577โ€“84.
  2. Bhatt DL, et al. (2019). Cardiovascular Risk Reduction with Icosapentaenoic Acid for Hypertriglyceridemia (REDUCE-IT). NEJM, 380(1), 11โ€“22.
  3. Yurko-Mauro K, et al. (2015). Docosahexaenoic acid and cognitive function. Prostaglandins, Leukotrienes and Essential Fatty Acids, 96, 1โ€“5.
  4. Schuchardt JP & Hahn A. (2013). Bioavailability of long-chain omega-3 fatty acids. European Journal of Lipid Science and Technology, 115(8), 875โ€“882.
  5. Calder PC. (2024). Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochemical Society Transactions, 45(5), 1105โ€“1115.